Envoy Medical
COCH
93 hedge funds and large institutions have $368M invested in Envoy Medical in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 15 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
54% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 13
2% more capital invested
Capital invested by funds: $362M → $368M (+$6.67M)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
1% less funds holding
Funds holding: 94 → 93 (-1)
1.13% less ownership
Funds ownership: 87.31% → 86.18% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$9.02M |
| 2 |
Jane Street
New York
|
+$5.21M |
| 3 |
CIM
Cowen Investment Management
New York
|
+$3.48M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$2.98M |
| 5 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$2.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$34M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$8.37M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$4.2M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$2.95M |
| 5 |
CF
Cantor Fitzgerald
New York
|
-$2.88M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CM
101
Crestline Management
Fort Worth,
Texas
| – | -$433K | -44,000 | Closed |
|
|
BCM
102
Basso Capital Management
Stamford,
Connecticut
| – | -$407K | -41,426 | Closed |
|
|
OFG
103
OTA Financial Group
Purchase,
New York
| – | -$356K | -36,271 | Closed |
|
104
Parallax Volatility Advisers
San Francisco,
California
| – | -$262K | -26,654 | Closed |
|
105
JP Morgan Chase
New York
| – | -$236K | -24,000 | Closed |
|
|
MIG
106
Mariner Investment Group
Harrison,
New York
| – | -$196K | -20,000 | Closed |
|
|
SSA
107
Schonfeld Strategic Advisors
New York
| – | -$130K | -13,201 | Closed |
|
|
CS
108
Clear Street
New York
| – | -$7K | -702 | Closed |
|
COCH Hedge Fund Activity: Q4 2022 in Review
93 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2022, worth a combined $368M — up 1.8% from $362M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of COCH and 14 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 20 added.
The largest buyer was Karpus Investment Management, adding an estimated $9.02M. The largest seller was Glazer Capital LLC, cutting an estimated $34M.
- 93 institutional investors held Envoy Medical (COCH) as of Q4 2022, down from 94 in Q3 2022.
- Funds reported $368M of Envoy Medical stock for Q4 2022, up 1.8% quarter-over-quarter.
- 14 funds opened new Envoy Medical positions in Q4 2022 and 15 closed out, a net change of -1 holder.
- The largest Envoy Medical buyer in Q4 2022 was Karpus Investment Management, an estimated $9.02M added.
- The largest Envoy Medical seller in Q4 2022 was Glazer Capital LLC, an estimated $34M sold.
Based on aggregated 13F filings for Q4 2022.